The adiponectin rs17300539 G ≥ A variant and nephropathy risk

Kidney International

Volumn 74, Issue 10, 2008, Pages 1361-

  Prior, Sarah L ^a   Javid, Jabaria ^a   Gill, Geoffrey V ^b   Bain, Steve C ^a   Stephens, Jeffrey W ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

DIABETIC NEPHROPATHY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 55249110405     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.474     Document Type: Letter

References (4)

1. Jorsal A, Tarnow L, Frystyk J et al. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int 2008; 74: 649-654.
2. Vionnet N, Tregouet D, Kazeem G et al. Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene. Diabetes 2006; 55: 3166-3174.
3. Patel A, Scott WR, Lympany PA et al. The TGF-beta 1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes. Diabet Med 2005; 22: 69-73.
4. Bain SC, Gill GV, Dyer PH et al. Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort). Diabet Med 2003; 20: 808-811.